Related Experiment Video

Updated: May 3, 2026

Murine Model of CD40-activation of B cells
12:24

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

12.0K

4-1BB (CD137), an inducible costimulatory receptor, as a specific target for cancer therapy

Dass S Vinay1, Byoung S Kwon2

  • 1Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, New Orleans, LA70112, USA.

BMB Reports
|February 7, 2014
PubMed

Insights

Targeting 4-1BB (CD137) enhances anti-tumor immunity by activating cytotoxic T lymphocytes (CTLs) and increasing IFN-γ. This review explores 4-1BB

Area of Science:

  • Immunology and Cancer Biology

Background:

  • Tumors effectively evade immune surveillance, necessitating advanced therapeutic strategies.
  • 4-1BB (CD137; TNFRS9) is a crucial costimulatory molecule regulating immune responses.
  • Targeting 4-1BB or its ligand (4-1BBL) shows promise for treating various conditions, including cancer.

Purpose of the Study:

  • To review the multifaceted aspects of 4-1BB-mediated anti-tumor responses.
  • To elucidate the underlying mechanisms driving 4-1BB's anti-cancer effects.
  • To discuss future research directions in 4-1BB-targeted cancer immunotherapies.

Main Methods:

  • In-depth analysis of existing literature on 4-1BB signaling pathways.
  • Review of studies investigating 4-1BB agonism in preclinical and clinical cancer models.
  • Examination of immune cell activation, particularly cytotoxic T lymphocytes (CTLs), and cytokine production.

Main Results:

  • 4-1BB activation is critical for enhancing CTL proliferation, survival, and effector functions.
  • 4-1BB signaling promotes significant production of key cytokines, such as interferon-gamma (IFN-γ).
  • These combined effects contribute to potent anti-tumor immunity and tumor regression.

Conclusions:

  • 4-1BB-mediated immune activation represents a promising strategy for cancer immunotherapy.
  • Understanding the intricate mechanisms of 4-1BB signaling is vital for optimizing therapeutic efficacy.
  • Further research into 4-1BB-targeted therapies holds significant potential for improving cancer treatment outcomes.

More Related Videos

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling07:51

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling

Published on: March 20, 2026

490
Generation of Human CD40-activated B cells13:27

Generation of Human CD40-activated B cells

Published on: October 16, 2009

14.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K